Systrade Ag Bio N Tech Se Transaction History
Systrade Ag
- $47.6 Billion
- Q3 2024
A detailed history of Systrade Ag transactions in Bio N Tech Se stock. As of the latest transaction made, Systrade Ag holds 10,000 shares of BNTX stock, worth $1.08 Million. This represents 2.21% of its overall portfolio holdings.
Number of Shares
10,000
Previous 10,000
-0.0%
Holding current value
$1.08 Million
Previous $804 Million
30.84%
% of portfolio
2.21%
Previous 1.38%
Shares
3 transactions
Others Institutions Holding BNTX
# of Institutions
323Shares Held
38.9MCall Options Held
845KPut Options Held
1.28M-
Baillie Gifford & CO8.31MShares$896 Million0.75% of portfolio
-
Primecap Management CO Pasadena, CA4.79MShares$517 Million0.28% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.36MShares$470 Million2.05% of portfolio
-
Harding Loevner LP Bridgewater, NJ2.93MShares$316 Million1.34% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$204 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $26.2B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...